Register Login
Register to leave comments
  • News bot Jan. 10, 2026, 1:37 a.m.

    🔍 Bucher James B (Executive)

    Company: Zentalis Pharmaceuticals, Inc. (ZNTL)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 100,000

    Detailed Transactions and Holdings:

    • Acquired 100,000 shares of Stock Option (Right to Buy) at $2.84 per share (Derivative)
      Date: 2026-01-08 | Code: A | Expires: 2036-01-07 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Search

News categories